Intradural extramedullary benign spinal lesions radiosurgery. Medium- to long-term results from a single institution experience
- 332 Downloads
Surgery represents the first-choice treatment for spinal intradural tumours. On the other hand, whether it is most appropriate in the setting of recurrences, residual or multiple lesions remains an open question. Moreover, some patients are less than ideal candidates for surgery. In this study we report about our own radiosurgery experience in the treatment of benign intradural extramedullary tumours of the spine.
In our study we analyzed the outcomes for 18 patients (21 lesions) treated for benign intradural extramedullary lesions, with a minimum follow-up period of 32 months. The lesions included 11 meningiomas, 9 schwannomas and 1 neurofibroma.
The mean follow-up was 43 months (32–73 months). The median tumour volume was 2 cc (0.2–17.7 cc). Eleven lesions underwent single-fraction treatment (mean prescribed dose ranging from 10 to 13 Gy). The others received a multisession radiosurgery treatment (4–6 fractions) with a mean prescription dose ranging from 18.5 to 25 Gy. The maximum dose to the spinal cord ranged from 9.2 to 26 Gy. During the follow-up period, none of the lesions showed radiological evidence of progression. Neurological status was preserved or improved and no permanent sequelae were observed. Significant and durable pain relief was observed.
Although surgical excision remains the primary treatment option for most intradural tumours, radiosurgery offers a real alternative therapeutic modality, especially in case of recurrent and residual lesions or when surgery is contraindicated.
KeywordsRadiosurgery Hypofractioned radiotherapy Meningiomas Neurinomas Neurofibromas Spine Cyberknife
The authors wish to thank Dr. David W. Schaal, Accuray Incorporated, for technical and editorial assistance.
Conflicts of interest
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
- 5.Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, Version 3.0 (2003) DCTD, NCI, NIH, DHHS. http://ctep.cancer.gov. Accessed 9 August 2006
- 6.Chang EL, Shiu AS, Lii MF, Rhines LD, Mendel E, Mahajan A, Weinberg JS, Mathews LA, Brown BW, Maor MH, Cox JD (2004) Phase I clinical evaluation of near-simultaneous computed tomography image guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 59:1288–1294PubMedCrossRefGoogle Scholar
- 16.Guidetti B, Fortuna A (1975) Differential diagnosis of intramedullary and extramedullary tumours. In: Vinken PJ, Bruyn JW (eds) Handbook of clinical neurology. Elsevier, Amsterdam, pp 51–75Google Scholar
- 39.Sahgal A, Chou D, Ames C, Ma L, Lamborn K, Huang K, Chuang C, Aiken A, Petti P, Weinstein P, Larson D (2007) Image-guided robotic stereotactic body radiotherapy for benign spinal tumors: the University of California San Francisco preliminary experience. Technol Cancer Res Treat 6(6):595–604PubMedGoogle Scholar
- 40.Santacroce A, Walier M, Régis J, Liščák R, Motti E, Lindquist C, Kemeny A, Kitz K, Lippitz B, Martínez Álvarez R, Pedersen PH, Yomo S, Lupidi F, Dominikus K, Blackburn P, Mindermann T, Bundschuh O, van Eck AT, Fimmers R, Horstmann GA (2012) Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70(1):32–39PubMedCrossRefGoogle Scholar
- 46.Weinstein JN, McLain RF (1992) Tumor of the spine. In: Rothman RH, Simeone FA (eds) The spine, vol 1. WB Saunders, Philadephia, pp 1639–1654Google Scholar